Synonyms: CVT-303 | Ranexa® | RS-43285 | RS-43285-003
ranolazine is an approved drug (FDA (2006), EMA (2008))
Compound class:
Synthetic organic
Comment: The mechanism of action of ranolazine is largely unknown, but may have some antianginal effects by inhibition of the late sodium current in cardiac cells.
![]() View more information in the IUPHAR Pharmacology Education Project: ranolazine |
|
References |
1. El-Bizri N, Kahlig KM, Shyrock JC, George Jr AL, Belardinelli L, Rajamani S. (2011)
Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants. Channels (Austin), 5 (2): 161-72. [PMID:21317558] |